System and method for performing alternative and sequential blood and peritoneal dialysis modalities

ABSTRACT

A dialysis system includes at least one source of fluid for dialysis, a fluid line in fluid communication with the at least one source of fluid, at least one pump positioned and arranged to pump fluid from the at least one source of fluid through the fluid line, a first patient connector configured to be removably placed in fluid communication with the fluid line to allow a blood treatment to be performed using the at least one source of fluid, and a second patient connector configured to be removably placed in fluid communication with the fluid line to allow a peritoneal dialysis treatment to be performed using the at least one source of fluid.

PRIORITY CLAIM

This application claims priority to and the benefit as a continuationapplication of U.S. patent application Ser. No. 13/828,731, entitled,“System and Method for Performing Alternative and Sequential Blood andPeritoneal Dialysis Modalities”, filed Mar. 14, 2013, the entirecontents of which is hereby incorporated by reference and relied upon.

CROSS-REFERENCE TO RELATED APPLICATION

This application is related by subject matter to U.S. patent applicationSer. No. 11/773,634, entitled, “Extracorporeal Dialysis Ready PeritonealDialysis Machine”, filed Jul. 5, 2007, and assigned to the assignee ofthe present application, the entire contents of which are herebyincorporated by reference and relied upon.

BACKGROUND

The examples discussed below relate generally to medical fluid delivery.More particularly, the examples disclose systems, methods andapparatuses for the control of fluid flow in kidney failure treatmentsystems.

Due to various causes, a person's renal system can fail. Renal failureproduces several physiological derangements. The balance of water,minerals and the excretion of daily metabolic load is no longer possibleand toxic end products of nitrogen metabolism (urea, creatinine, uricacid, and others) can accumulate in blood and tissue.

Kidney failure and reduced kidney function have been treated withdialysis. Dialysis removes waste, toxins and excess water from the bodythat would otherwise have been removed by normal functioning kidneys.Dialysis treatment for replacement of kidney functions is critical tomany people because the treatment is life saving.

Hemodialysis and peritoneal dialysis are two types of dialysis therapiesused commonly to treat loss of kidney function. A hemodialysis (“HD”)treatment utilizes the patient's blood to remove waste, toxins andexcess water from the patient. The patient is connected to ahemodialysis machine and the patient's blood is pumped through themachine. Catheters are inserted into the patient's veins and arteries sothat blood can flow to and from the hemodialysis machine. The bloodpasses through a dialyzer of the machine, which removes waste, toxinsand excess water from the blood. The cleaned blood is returned to thepatient. A large amount of dialysate, for example about 80 to 120liters, is consumed during a single hemodialysis therapy. Hemodialysistreatment lasts several hours and is generally performed in a treatmentcenter about three or four times per week.

Another form of kidney failure treatment involving blood ishemofiltration (“HF”), which is an alternative renal replacement therapythat relies on a convective transport of toxins from the patient'sblood. This therapy is accomplished by adding substitution orreplacement fluid to the extracorporeal circuit during treatment(typically ten to ninety liters of such fluid). That substitution fluidand the fluid accumulated by the patient in between treatments isultrafiltered over the course of the HF treatment, providing aconvective transport mechanism that is particularly beneficial inremoving middle and large molecules.

Hemodiafiltration (“HDF”) is another blood treatment modality thatcombines convective and diffusive clearances. HDF uses dialysate to flowthrough a dialyzer, similar to standard hemodialysis, providingdiffusive clearance. In addition, substitution solution is provideddirectly to the extracorporeal circuit, providing convective clearance.

Peritoneal dialysis uses a dialysis solution, also called dialysate,which is infused into a patient's peritoneal cavity via a catheter. Thedialysate contacts the peritoneal membrane of the peritoneal cavity.Waste, toxins and excess water pass from the patient's bloodstream,through the peritoneal membrane and into the dialysate due to diffusionand osmosis, i.e., an osmotic gradient occurs across the membrane. Thespent dialysate is drained from the patient, removing waste, toxins andexcess water from the patient. This cycle is repeated.

There are various types of peritoneal dialysis therapies, includingcontinuous ambulatory peritoneal dialysis (“CAPD”), automated peritonealdialysis (“APD”), tidal flow dialysis and continuous flow peritonealdialysis (“CFPD”). CAPD is a manual dialysis treatment. The patientmanually connects an implanted catheter to a drain, allowing spentdialysate fluid to drain from the peritoneal cavity. The patient thenconnects the catheter to a bag of fresh dialysate, infusing freshdialysate through the catheter and into the patient. The patientdisconnects the catheter from the fresh dialysate bag and allows thedialysate to dwell within the peritoneal cavity, wherein the transfer ofwaste, toxins and excess water takes place. After a dwell period, thepatient repeats the manual dialysis procedure, for example, four timesper day, each treatment lasting more than an hour. Manual peritonealdialysis requires a significant amount of time and effort from thepatient, leaving ample room for improvement.

Automated peritoneal dialysis (“APD”) is similar to CAPD in that thedialysis treatment includes drain, fill, and dwell cycles. APD machines,however, perform the cycles automatically, typically while the patientsleeps. APD machines free patients from having to manually perform thetreatment cycles and from having to transport supplies during the day.APD machines connect fluidly to an implanted catheter, to a source orbag of fresh dialysate and to a fluid drain. APD machines pump freshdialysate from a dialysate source, through the catheter, into thepatient's peritoneal cavity, and allow the dialysate to dwell within thecavity, and allow the transfer of waste, toxins and excess water to takeplace. The source can be multiple sterile dialysate solution bags.

APD machines pump spent dialysate from the peritoneal cavity, though thecatheter, to the drain. As with the manual process, several drain, filland dwell cycles occur during dialysate. A “last fill” sometimes occursat the end of APD, which remains in the peritoneal cavity of the patientuntil the next treatment.

Both CAPD and APD are batch type systems that send spent dialysis fluidto a drain. Tidal flow systems are modified batch systems. With tidalflow, instead of removing all of the fluid from the patient over alonger period of time, a portion of the fluid is removed and replacedafter smaller increments of time.

Continuous flow, or CFPD, systems clean or regenerate spent dialysateinstead of discarding it. The systems pump fluid into and out of thepatient, through a loop. Dialysate flows into the peritoneal cavitythrough one catheter lumen and out another catheter lumen. The fluidexiting the patient passes through a reconstitution device that removeswaste from the dialysate, e.g., via a urea removal column that employsurease to enzymatically convert urea into ammonia. The ammonia is thenremoved from the dialysate by adsorption prior to reintroduction of thedialysate into the peritoneal cavity. Additional sensors are employed tomonitor the removal of ammonia. CFPD systems are typically morecomplicated than batch systems.

It is known with PD therapy that the diffusive properties of theperitoneum degrade over time due at least in part to chronic exposure toglucose. While research has been done to find an alternative osmoticagent, glucose remains the industry standard. Accordingly, a need existsfor an improved PD therapy, which addresses the degradation of theeffectiveness of the diffusive properties of the peritoneum over time.

SUMMARY

The examples below describe systems that provide an improved dialysistreatment. The systems address the degradation of clearanceeffectiveness of PD due to the chronic exposure of the peritoneum toglucose. In one preferred implementation of the systems described below,the systems are tailored to be used by the patient at home. It should beappreciated however that the machines are not limited to at home use andcan instead be adapted for in-center or hospital use.

The systems in general provide an opportunity to the patient toalternate between peritoneal dialysis (“PD”) and hemodialysis (“HD”).Alternating therapies provides two primary advantages, namely,preserving maximum residual renal function in PD and obtaining maximumurea clearance through HD. The systems provide “peritoneal rest” byenabling patients to perform HD over given intervals of time.Preliminary studies (⁽¹⁾: Tomo T. et al J Artif Organs, 2005; 8(2):125-9;⁽²⁾ Zareie M., et al, Nephrol Dial Transplant, 2005 January;20(1): 189-93;⁽³⁾ Rodriquez A., Advanced Peritoneal Dialysis, 2002;18:7880) indicate that “peritoneal rest” after one or more PD treatmentallows the peritoneum to heal at least to some degree prior to the nextexposure to glucose.

Disclosed below are three primary embodiments, namely, HD in combinationwith online batch PD, HD in combination with online continuous flowperitoneal dialysis (“CFPD”), and HD in combination with a simplified orbagged dialysate batch PD. In each of the three combinations, the HDtherapy is the same, which is in one embodiment performed by making HDdialysate online and delivering the dialysate to and across the dialyzerto drain, while a blood pump pumps blood from a patient, to a dialyzer,cleaning the blood, and from the dialyzer, back to the patient.

In combination with the HD therapy, the first, online batch PD therapyswaps out the concentrates used to make HD dialysate with a PD dialysateconcentrate and possibly a chemical disinfectant. The HD system hotwater disinfects all blood and dialysate lines after a treatment in oneembodiment. A subsequent PD treatment may also require that a chemicaldisinfectant be used alternatively or additionally with the hot waterdisinfection due to the fact that PD dialysate is delivered directly tothe patient, heightening the need to high purity or sterility.

The online batch PD treatment primes the entire system with PDdialysate, after which a PD connection set 100 is connected to theprimed and reused arterial and venous lines. The PD connection set isitself primed via pumping or gravity, after which the PD connection setis placed in fluid communication with the patient's transfer set. BatchPD dialysis is then performed with multiple fill, dwell and drain (fullor tidal drains) cycles. Each drain cycle removes an amount ofultrafiltrate (“UF”) absorbed via an osmotic gradient provided by the PDdialysate. If needed, an initial drain can be performed to remove a PDlast fill from a patient's previous PD treatment.

In combination with the HD therapy, the second, CFPD therapy also swapsout the concentrates used to make HD dialysate with a PD dialysateconcentrate and possibly the chemical disinfectant. The CFPD therapy canprime all lines the same as with the online batch PD treatment.

One primary difference between online batch PD and CFPD is that the CFPDconnection set is a dual lumen connection set, while the online batch PDconnection set can be a single lumen connection set that Y's or T's toconnect to both the arterial and venous lines. The dual lumen CFPDconnection set enables PD dialysate to be delivered to and removed fromthe patient's peritoneum simultaneously.

Another primary difference between CFPD and batch online PD is that CFPDflows PD dialysate continuously across the outsides of the dialyzermembranes to drain, while batch online PD pushes PD dialysate across thedialyzer membranes, into the PD patient circuit, into the patient forbatch filling, and then stops. CFPD flows PD dialysate continuously onboth sides of the dialyzer membranes in a manner similar to HD. The PDdialysate on the outsides of the dialyzer membranes osmotically cleansthe PD dialysate on the insides of the dialyzer membranes, so that thePD dialysate delivered to the patient is continuously freshened. Again,the PD dialysate on the outside of the dialyzer membranes, whichosmotically pulls patient waste products from the PD dialysate on theinsides of the dialyzer membranes, is delivered to drain in oneembodiment.

In combination with the HD therapy, the third, bagged dialysate batch PDtherapy does not make dialysate online. Instead, a source of PDdialysate, such as a bag or container, is used. A single line patientconnection set is used instead of the “Y” or “T” patient connection setused with online batch PD. The HD blood pump is used to pull PDdialysate from the source and push the PD dialysate through thedialyzer, the venous line and the single line patient connection set forpriming, and then to the patient once priming is completed.

After a specified dwell period, the used dialysate or from-dialyzerdialysate pump is used to pull spent dialysate from the patient, acrossthe dialyzer membranes, to drain. A new fill cycle can then becommenced. If the container is a single fill container, which is expiredafter the first fill, the blood pump can alternatively be used to drainthe patient and push the effluent dialysate back to the source.

Multiple pneumatic configurations for pumping at higher pressures(positive and negative) for HD and at lower pressures (positive andnegative) for PD are disclosed. Providing multiple pneumatic storagetanks with selective valving and/or providing electrically variablepressure regulators are examples discussed in detail below for providinghigher pressures on HD therapy days and lower pressures on PD therapydays.

An alternative electrically controlled configuration is also disclosed.The pumps, and valves of the present disclosure are not limited topneumatic pumps and valves. Peristaltic pumps operating with volumetricmetering devices and solenoid pinch clamps, as disclosed below, may beused alternatively.

It is an advantage of the present disclosure to provide combinationhemodialysis and peritoneal dialysis systems that can providealternative therapies to the same patient on different days.

Another advantage of the present disclosure is to provide a singlestructure yielding multiple systems for automatically performingdifferent modalities of dialysis as desired or prescribed.

A further advantage of the present disclosure is to provide a singlestructure that can pump at different pressures for different treatmentmodalities or therapies.

It is still another advantage of the patient disclosure to providesystems and methods that reuse the same (or largely the same)disposables for different therapies or treatment modalities.

It is yet another advantage of the patient disclosure to provide onlinesystems and methods that can be used for multiple therapies or treatmentmodalities.

Additional features and advantages are described herein, and will beapparent from, the following Detailed Description and the figures.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a schematic view of one embodiment of a hemodialysis (“HD”)system of the present disclosure.

FIG. 2 is a schematic view of one embodiment of an online batchperitoneal dialysis (“PD”) system in a filling mode, which can be usedto perform an alternative PD therapy to the HD therapy of FIG. 1.

FIG. 3 is a schematic view of the online batch PD system of FIG. 2 in adraining mode.

FIG. 4 is a schematic view of one embodiment of an online continuousflow peritoneal dialysis (“CFPD”) system in a filling mode, which can beprovided to perform an alternative therapy to the therapy of the HDsystem of FIG. 1.

FIG. 5 is a schematic view of the CFPD system of FIG. 4 in a drainingmode.

FIG. 6 is a schematic view of one embodiment of a container sourcedbatch PD system in a filling mode, which can be used to perform analternative therapy to the therapy of HD system of FIG. 1.

FIG. 7 is a schematic view of the container sourced batch PD system ofFIG. 6.

FIG. 8 is a schematic view of one embodiment of a pneumaticconfiguration that can be used with any of the combinations of systemsdiscussed herein to provide the different operating pressures requiredfor HD versus PD.

FIG. 9 is another embodiment of a pneumatic configuration that can beused with any of the combinations of systems discussed herein to providethe different operating pressures required for HD versus PD.

FIG. 10 is a schematic view of an alternative electrically driven systemof the present disclosure, which can supply the different operatingpressures required for HD versus PD.

DETAILED DESCRIPTION HD and Batch PD

Referring now to the drawings and in particular to FIG. 1, oneembodiment for a combined PD/HD system is illustrated by system 10 a.FIG. 1 is a simplified version of a hemodialysis (“HD”) system. System10 a and any of the systems discussed here can include any of thestructure and functionality described in U.S. Publication No.2008/0216898, entitled, “Cassette System Integrated Apparatus”, filedFeb. 27, 2008, and in U.S. Publication No. 2013/0037480, entitled,“Hemodialysis Systems And Methods”, filed Aug. 8, 2012, the entirecontents of each of which (referred to herein as the “referencedpublications”) are hereby incorporated by reference and relied upon.Generally, the systems shown herein include a very simplified version ofthe dialysate or process fluid delivery circuit. The blood circuits arealso simplified but not to the degree that the dialysate circuit issimplified. It should be appreciated that the circuits have beensimplified to make the description of the present disclosure easier, andthat the systems if implemented would have additional structure andfunctionality, such as is found in the referenced publications listedabove.

System 10 a of FIG. 1 includes a blood circuit 20. Blood circuit 20pulls blood from and returns blood to a patient 12. Blood is pulled frompatient 12 via an arterial line 14, and is returned to the patient via avenous line 16. Arterial line 14 includes an arterial line connector 14a that connects to an arterial needle 14 b, which is in blood draw flowcommunication with patient 12. Venous line 16 includes a venous lineconnector 16 a that connects to a venous needle 16 b, which is in bloodreturn flow communication with the patient. Arterial and venous lines 14and 16 also include line clamps 18 a and 18 v, which can be aspring-loaded, fail safe mechanical pinch clamps. Line clamps 18 a and18 v are closed automatically in an emergency situation in oneembodiment.

Arterial and venous lines 14 and 16 also include air or bubble detectors22 a and 22 v, respectively, which can be ultrasonic air detectors. Airor bubble detectors 20 a and 20 v look for air in the arterial andvenous lines 14 and 16, respectively. If air is detected by one of airdetectors 22 a and 22 v, system 10 a closes line clamps 18 a and 18 v,pauses the blood and dialysate pumps and provides instructions to thepatient to clear the air so that treatment can resume.

A blood pump 30 is located in arterial line 14 in the illustratedembodiment. In the illustrated embodiment, blood pump 30 includes afirst blood pump pod 30 a and a second blood pump pod 30 b. Blood pumppod 30 a operates with an inlet valve 32 i and an outlet valve 32 o.Blood pump pod 30 b operates with an inlet valve 34 i and an outletvalve 34 o. In an embodiment, blood pump pods 30 a and 30 b are eachblood receptacles that include a hard outer shell, e.g., spherical, witha flexible diaphragm located within the shell, forming a diaphragm pump.Once side of each diaphragm receives blood, while the other side of eachdiaphragm is operated by negative and positive air pressure.

To operate blood pump pods 30 a and 30 b, taking pod 30 a for example,inlet valve 32 i is opened, while outlet valve 32 o is closed, and whilenegative air pressure is applied to the diaphragm to draw blood intoblood pump pod 30 a. Conversely, inlet valve 32 i is closed, whileoutlet valve 32 o is opened, and while positive air pressure is appliedto the diaphragm to push blood out of blood pump pod 30 a. The same isdone for blood pump pod 30 b using inlet valve 34 i and an outlet valve34 o. In one embodiment, blood pump pods 30 a and 30 b are operatedsequentially so that while blood pump pods 30 a is drawing in blood,blood pump pod 30 b is pushing blood out, and vice versa. This allowsblood flow to be relatively continuous through dialyzer 40.

A heparin vial 24 and heparin pump 26 are located between blood pump 30and dialyzer 40 in the illustrated embodiment. Heparin pump 26 can be apneumatic pump or a syringe pump (e.g., stepper motor driven syringepump) as desired. Supplying heparin upstream of dialyzer 40 helps toprevent clotting of the dialyzer membranes.

A control unit 50 includes one or more processor and memory, receivesair detection signals from air detectors 22 a and 22 v (and othersensors of system 10 a, such as temperature sensors, blood leakdetectors, conductivity sensors and pressure sensors), and controlscomponents such as line clamps 18 a and 18 v, blood pump 30, heparinpump 26, and the dialysate pumps (described below).

Blood exiting dialyzer 40 flows through an airtrap 28. Airtrap 28removes any air from the blood before the dialyzed blood is returned topatient 12 via venous line 16. Airtrap 28 can also have a pierceableseptum that allows blood samples to be removed from blood circuit 20.Air that escapes airtrap 28 is sensed by venous air detector 22 v.Control unit 50 receives the air sensed signal from venous air detector22 v and causes line clamps 18 a and 18 v to close and the userinterface of system 10 a (which in one embodiment is a tablet userinterface) to display a clear air alarm screen. Arterial air detector 22a helps to detect whether arterial line connector 14 a is properlyconnected to arterial needle 14 b. At the end of prime, system 10 a canpull blood from the patient into the arterial line 14 and venous line16. At that time, venous air detector 22 b can be used with control unit50 detect whether venous line connector 16 a is properly connected tovenous needle 16 b.

With hemodialysis system 10 a of FIG. 1, dialysis fluid or dialysate ispumped along the outside of the membranes of dialyzer 40, while blood ispumped through the insides of the dialyzer membranes. Dialysis fluid ordialysate is prepared beginning with the purification of water by waterpurification unit 60. One suitable water purification unit is set forthin U.S. Patent Publication No. 2011/0197971, entitled, “WaterPurification System and Method”, filed Apr. 25, 2011, the entirecontents of which are incorporated herein by reference and relied upon.In one embodiment, water purification unit includes filters and otherstructure to purify tap water (e.g., remove pathogens and ions such aschlorine) so that the water is in one implementation below 0.03endotoxin units/ml (“EU/ml”) and below 0.1 colony forming units/ml(“CFU/ml”). Water purification unit 60 can be provided in a housingseparate from the housing of the hemodialysis machine, which includesblood circuit 20 and a dialysate circuit 70.

Dialysate circuit 70 is again highly simplified in FIG. 1 to easeillustration and to better highlight blood circuit 20. Dialysate circuit70 in actuality can include all of the relevant structure andfunctionality set forth in the referenced publications. Certain featuresof dialysate circuit 70 are illustrated in FIG. 1. In particular,dialysate circuit 70 includes a to-dialyzer dialysate pump 64. Pump 64is in one embodiment configured the same a blood pump 30. Pump 64, likepump 30, includes a pair of pump pods, which again can be sphericallyconfigured. Only one pump pod 66 is illustrated, however, two pump podsare provided as with blood pump 30 in one embodiment. Inlet valve 68 iand outlet valve 68 o are sequenced with pump pod 66 to pull fluid intothe pod (inlet valve 68 i open, while outlet valve 68 o closed) and topush fluid out of the pod (inlet valve 68 i closed, while outlet valve68 o opened). The two pump pods, like with blood pump 30, are operatedalternatingly so that one pump pod is filling with HD dialysate, whilethe other pump pod is expelling HD dialysate.

Pump 64 is a to-dialyzer dialysate pump. There is another dual pod pump96, like pump 64, located in drain line 82 to push used dialysate todrain. There is a third pod pump (not illustrated) used to pump purifiedwater through bicarbonate cartridge 72. There is a fourth pod pump (notillustrated) used to pump acid from container 74 into missing line 62.The third and fourth pumps, the concentrate pumps, can be single podpumps because continuous pumping is not as important in mixing line 62because there is a buffering dialysate tank (not illustrated) betweenmixing line 62 and to-dialyzer dialysate pump 64 in one embodiment. Afifth pod pump (not illustrated) provided in drain line 82 is used toremove a known amount of ultrafiltration (“UF”) when the HD therapy isprovided.

Purified water from water purification unit 60 is pumped along a mixingline 62 though a bicarbonate cartridge 72. Acid from a container 74 ispumped along mixing line 62 into the bicarbonated water flowing frombicarbonate cartridge 72 to form an electrolytically and physiologicallycompatible dialysate solution. The pumps and temperature-compensatedconductivity sensors used to properly mix the purified water with thebicarbonate and acid are not illustrated but are disclosed in detail inthe referenced publications.

FIG. 1 also illustrates that dialysate is pumped along a fresh dialysateline 76, through a heater 78 and an ultrafilter 80, before reachingdialyzer 40 and dialyzing blood of patient 12, after which the useddialysate is pumped to drain via drain line 82. Heater 78 heats thedialysate to body temperature or about 37° C. Ultrafilter 80 furthercleans and purifies the dialysate before reaching dialyzer 40, filteringbugs or contaminants introduced for example via bicarbonate cartridge 72or acid container 74 from the dialysate.

Dialysate circuit 70 also includes a sample port 84 in the illustratedembodiment. Dialysate circuit 70 will further include a blood leakdetector (not illustrated but used to detect if a dialyzer fiber istorn) and other components that are not illustrated, such as balancechambers, plural valves, and a dialysate holding tank, all illustratedand described in detail in the referenced applications.

Hemodialysis system 10 a is an online, pass-through system that pumpsdialysate through the dialyzer one time and then pumps the useddialysate to drain. Both blood circuit 20 and dialysate circuit 70 arehot water disinfected after each treatment, such that blood circuit 20and dialysate circuit 70 can be reused. In one implementation, bloodcircuit 20 including dialyzer 40 are hot water disinfected and reuseddaily for about one month, while dialysate circuit 70 is hot waterdisinfected and reused for about six months. Prior to running the hotwater disinfections, system 10 a returns or rinses back the blood topatient 12. To do so, system 10 a in one embodiment pushes dialysateacross dialyzer 40 into blood circuit 20, which in turn pushes bloodthough both arterial and venous lines 14 and 16 back to patient 12. Inan embodiment, system 10 a knows how much dialysate to push into bloodcircuit 20 by knowing the volume of the blood circuit and counting knownvolume pump strokes until that volume is reached. Alternatively oradditionally, a blood leak detector can be added to blood circuit 20 tolook for a color change (from blood to clear) to know when to stop theblood rinseback process. In any case, at the end of the hemodialysistreatment, both circuits 20 and 70 are filled with dialysate.

Referring now to FIGS. 2 and 3, system 10 b, using largely the sameequipment as HD system 10 a, is used instead to perform peritonealdialysis. As discussed above in the SUMMARY, it has been reported thatthere are therapeutic benefits to alternating or mixing in peritonealdialysis treatments into a hemodialysis regime and vice versa. System 10(referring collectively to systems 10 a and 10 b) allows hemodialysis tobe performed one day and the peritoneal dialysis to be performed thenext day, and so on. Each element numbered the same in FIGS. 1 to 3includes all of the structure, functionality and alternatives discussedherein, for example, as discussed in connection with FIG. 1. There are afew differences discussed next between the structure of hemodialysissystem 10 a in FIG. 1 and the structure of peritoneal dialysis system 10b as illustrated in FIGS. 2 and 3.

One primary difference is that bicarbonate cartridge 72 and acidcontainer 74 of hemodialysis system 10 a have been replaced by disinfectsource 86 and peritoneal dialysis concentrate source 88 in FIGS. 2 and3. Disinfect source 86 is used after the previous treatment, e.g., ahemodialysis treatment, during disinfection. Again, in one embodimentdialysis system 10 (referring to both systems 10 a and 10 b) heatdisinfects blood circuit 20 and dialysate circuit 70 after treatment. Ifperitoneal dialysis is to be performed in the next treatment, theneither before or after the hot water disinfection, system 10 b operatesa cycle in which a disinfectant is run through blood circuit 20 anddialysate circuit 70, e.g., over multiple passes, so that any bugs orcontaminants left after the hot water disinfection has taken place arekilled or removed to drain. This is done because instead of blood beingpumped through blood circuit 20 in the next treatment, peritonealdialysis fluid will be pumped through dialyzer 40, into arterial line 14and venous line 16, and directly into patient 12. Accordingly,peritoneal dialysis system 10 b must be as sterile as possible.

Suitable disinfectants for source 86 include renalin and peracetic acid,sold by under tradenames, such as Pericidin™, Actril™, Peristeril Plus™and Puristeril 340™ and Minncare™. System 10 b can in an embodimentproportion peracetic acid to a concentration of about 1% and deliversame to both circuits 20 and 70. Actril™ solution can be partiallypre-diluted and then proportioned by system 10 b to achieve the desiredconcentration. Another suitable disinfectant for source 86 is sodiumhypochlorite (household bleach) provided at about five to six percentstrength. Sodium hypochlorite can be used intermittently, e.g., once aweek and, is particularly useful in removing organic deposits. System 10b can dilute sodium hypochlorite down to a 100 to 500 parts per million(“ppm”). One source of sodium hypochlorite is sold under the tradenameTuitol KF™ at 3.9% concentration. A further suitable disinfectant forsource 86 is sold under the tradename Sporotal 100™, which includessodium hypochlorite with potassium hydroxide and corrosion inhibitors,and which is particularly useful in removing biofilms.

System 10 b in an embodiment rinses circuits 20 and 70 free of dialysissolution, introduces one of the disinfectants listed above, allows thedisinfectant to dwell for a specified period of time, rinses thedisinfectant out of circuits 20 and 70, and checks for residualdisinfectant prior to use. The conductivity sensors (illustrated in thereferenced publications) provided by systems 10 a and 10 b can be usedto detect the presence or absence of disinfectant, e.g., for both bleachand peracetic acid, to ensure no disinfectant remains at the time of thenext patient treatment. Alternatively or additionally, a residualdisinfectant check can be performed by patient 12, nurse or caregiverusing a test strip, e.g., a pH test strip, which can be specific to thedisinfectant type. The chemical disinfectant can be performed before orduring the hot water disinfect cycle or be performed after the hot waterdisinfection cycle and be followed by an additional hot waterdisinfections cycle.

Alternatively or additionally, during the hot water disinfection cycle,small amounts of anhydrous sodium carbonate powder (e.g., 13 grams) canbe diluted by the proportioning or mixing circuit of systems 10 a and 10b and used as a chemical during the heat disinfection cycle to removeorganic deposits, fats and proteins.

Alternatively or additionally, during the hot water disinfection cycle,small amounts of citric acid anhydrate powder, e.g., 32 grams, can bediluted by the proportioning or mixing circuit of systems 10 a and 10 bas a chemical to disinfect and decalcify. Citric acid improves thedisinfect efficiency because an 80° C. to 90° C. citric acid watersolution will kill spore forming bacteria.

Alternatively or additionally, during the hot water disinfection cycle,citric acid liquid can be diluted by the proportioning or mixing circuitof systems 10 a and 10 b as a chemical to disinfect and decalcify.Again, citric acid liquid improves the disinfect efficiency because an80° C. to 90° C. citric acid water solution will kill spore formingbacteria.

Alternatively or additionally, during the hot water disinfection cycle,hydroxy acetic acid and water under the tradename Diasteril™ can be usedfor chemical and heat disinfection similar to the citric acid heattreatment.

The heat disinfection cycle in an embodiment heats the water to 80° C.to 90° C., e.g., for fifteen minutes to one hour, and then coolscircuits 20 and 70 with cool fresh water. In further alternativeautoclave embodiment, heater 78 heats water to 120° C. and recirculatesthe hot water/steam, e.g., for fifteen minutes to one hour, throughcircuits 20 and 70 before cooling the circuits with cool fresh water.

In an embodiment, the pump used to pump purified water throughbicarbonate cartridge 72 in FIG. 1 is used instead to pump disinfectantfrom source 86 in FIGS. 2 and 3. The pump used to pump acid fromcontainer 74 in FIG. 1 is used instead to pump peritoneal dialysis fluidconcentrate from container 88. Disinfectant from source 86 can beprovided in concentrated form and mixed with water from purificationsource 60 to provide a suitable volume of disinfection fluid, in asuitable concentration, to disinfect the entire system 10 b.

In an embodiment, disinfection source 86 is provided in a volume sizedto be used completely in one use. Control unit 50 knows the volume ofdisinfection source 86 and also the volume of fluid pumped by eachstroke of the pod pump used to pump disinfectant from source 86. In thismanner, control unit 50 can count full strokes of the disinfectantsource pump and tally the amount of disinfectant pumped from the sourceuntil the full volume of disinfectant is removed from source 86. Thedisinfectant and purified water mixture is then circulated around andaround system 10 b. When chemical disinfection is completed, thedisinfectant and purified water mixture is then pumped to drain viadrain line 82, allowing system 10 b to dry for the next treatment, whichwill be a peritoneal dialysis treatment.

Alternatively or in addition to chemical disinfection, peritonealdialysis system 10 b can use steam disinfection or ozone forsterilization. Ozone can be created online by subjecting oxygen toultraviolet light. The ozone can then be drawn into purified water inmixing line 62, e.g., via a venture pump. Ozone tends not to store wellunder positive pressure.

Control unit 50 also knows the volume of fluid pumped by each stroke ofthe pod pump used to pump peritoneal dialysis fluid concentrate fromcontainer 88. In this manner, control unit 50 can count full strokes ofthe concentrate pump and tally the amount of concentrate pumped fromcontainer 88, so that the concentrate is mixed in the proper or desiredproportion with purified water.

Hemodialysis dialysate is made in an embodiment using conductivityprobes. When the dialysate reads the proper concentration, the dialysateis mixed properly. Peritoneal dialysis fluid is proportioned insteadvolumetrically in one embodiment using a known volume of purified waterfrom unit 60 mixed with a known volume of concentrate, the volumes beingknown again by knowing the volume of each water pump stroke and eachconcentrate pump stroke. In an alternative embodiment, one or moresensor is used to servo the peritoneal dialysis fluid mixing, as is donewith the hemodialysis fluid mixing. Sensors for servoing the peritonealdialysis fluid mixing may include conductivity sensors and/or glucosesensors. Peritoneal dialysis concentrate for container 88 can includeany one or more of dextrose, icodextrin, amino acids or bicarbonate. Inan alternative embodiment, water purification unit 60 and concentratecontainer 88 are not used and bagged, premade peritoneal dialysis fluidis used instead to feed outer (meaning in fluid communication with theoutsides of the dialyzer membranes) dialysate circuit 70.

Pump 64 pumps the online peritoneal dialysis fluid through heater 78 andultrafilter 80 and into dialyzer 40 as illustrated in FIG. 2.Ultrafilter 80 and dialyzer 40 both serve to further purify theperitoneal dialysis (“PD”) fluid before the fluid enters a PD patientcircuit 90. PD patient circuit 90 in FIGS. 2 and 3 replaces bloodcircuit 20 in FIG. 1. Here, the hemodialysis needles 14 b and 16 b arereplaced by a PD connection set 100. PD connection set 100 includes apatient line 102 that connects to the PD transfer set of patient 12. Thepatient's PD transfer set connects to a PD catheter dwelling insidepatient 12. PD connection set 100 also includes a leg 104 that connectsfluidly to arterial line connector 14 a, and a leg 106 that connectsfluidly to venous line connector 16 a. PD connection set 100 furtherincludes a small single use filter 108, such as a small ultrafilter,which acts as a final barrier against any bugs or contaminants enteringpatient 12.

Prior to connecting PD connection set 100 to arterial line connector 14a and venous line connector 16 a, connectors 14 a and 16 a are connectedtogether forming a closed loop that has been hot water and chemicallydisinfected, then dried. To-dialysate pump 64 pumps filtered PD fluidinto PD patient circuit 90, where blood pump 30 circulates the PD fluidto push air through dialyzer 40 to drain via drain line 82 and opendrain valve 92. When PD patient circuit 90 is fully primed, lines 14 and16 are clamped, e.g., via manual pinch clamps such as Roberts™ clamps,connectors 14 a and 16 a are disconnected from each other and connectedto PD connection set 100. Patient line 102 can have a removablehydrophobic tip or be placed at the same elevation as dialyzer 40, sothat when lines 14 and 16 are unclamped, PD dialysate flows through PDconnection set 100, pushing air out though patient line 102.

Patient line 102 is then connected to the patient's transfer set anddrain valve 92 is closed. The patient can now be filled with PDdialysate as illustrated in FIG. 2. To do so in the illustratedembodiment, to-dialysate pump 64 pumps filtered PD fluid through venousline 16 to patient 12, while blood pump 30 pushes filtered PD fluidthrough arterial line 14 to patient 12. Alternatively, only one ofto-dialysate pump 64 or blood pump 30 pushes filtered PD to patient 12.It does not matter which line 14 or 16 is used to deliver PD dialysateto patient 12. Further alternatively, PD connection set 100 may onlyinclude one of legs 104 and 106, which connects to one of connectors 14a and 16 a, only. The other connector 14 a or 16 a is plugged or cappedafter priming.

Control unit 50 knows how much PD dialysate is delivered from primed PDpatient circuit 90 to patient 12 again by counting known volume pumpstrokes of one or both of to-dialysate pump 64 or blood pump 30 in oneembodiment. Once the patient's peritoneum is filled with a prescribedfill volume, control unit 50 stops to-dialysate pump 64 and/or bloodpump 30. The PD dialysate is then allowed to reside or dwell within thepatient's peritoneum for a prescribed amount of time.

As illustrated in FIG. 3, when the prescribed dwell period has ended,control unit 50 opens drain valve 92 and closes delivery valve 94 infresh dialysate line 76 to perform a drain phase. Valve 94 is openduring the fill phase. To drain the patient, control unit 50 causesblood pump 30 and/or a from-dialyzer pump 96, operating with valves 98 iand 98 o as has been described herein, to pull the fill volume's worthof used PD dialysate and an expected amount of ultrafiltrate (“UF”) frompatient 12 and push same to drain via drain line 82. Control unit 50again relies on pump stroke counting for volumetric accuracy to drainpatient 12.

Control unit 50 then repeats the above-described fill, dwell and drainprocess. If patient 12 uses system 10 b to perform peritoneal dialysisfor multiple treatments in a row, the patient may have a full peritoneumfrom a last fill performed during a prior PD treatment when firstconnecting to PD patient circuit 90. If so, patient 12 can informcontrol unit 50 of same. Or, control unit 50 may already know thatpatient 12 needs to be drained and prompts the patient to do so. Ineither case, control unit 50 performs an initial drain through primed PDpatient circuit 90 first before performing a first fill. In analternative embodiment, patient 12 is prompted to perform a manual drainand enter the drain weight into control unit 50 before connecting to PDpatient circuit 90.

HD and Continuous Flow PD

It should be appreciated that PD system 10 b is a batch PD system inwhich PD fluid is pumped to patient 12, dwells within the patient and isthen removed from the patient to drain. Batch PD system 10 b can attemptto drain all the PD fluid in the drain cycle or only a portion of the PDfluid in what is known as tidal flow PD. Referring now to FIGS. 4 and 5,hemodialysis system 10 a of FIG. 1 is used instead in any desiredalternating treatment sequence with a continuous flow peritonealdialysis (“CFPD”) system 10 c. CFPD system 10 c is structurally verysimilar to that of batch PD system 10 b, so like element numbers,including all structure, function and alternatives discussed above inFIGS. 2 and 3, are repeated and are included in FIGS. 4 and 5.

For the combination of systems 10 a and 10 c, hemodialysis takes placejust like above with FIG. 1. Hemodialysis system 10 a is hot waterdisinfected after treatment, and if a next treatment is scheduled orselected to be a PD treatment, chemical disinfectant from source 86 canbe used to additionally sterilize circuits 70 and 90. Chemicaldisinfectant from source 86 is metered into purified water from unit 60in the same manner described above for FIG. 2.

For CFPD system 10 c, batch PD connection set 100 of system 10 b isreplaced with a CFPD connection set 110. CFPD connection set 110 usesdual lumens 114 and 116 instead of the “Y” or “T” connector 102, 104,106 of batch PD connection set 100. Arterial lumen 114 is connectedremovably to arterial line connector 14 a of arterial line 14, whilevenous lumen 116 is connected removably to venous line connector 16 a ofvenous line 16, via the last chance, single use filter 108 in theillustrated embodiments. Filter 108 can again be a final ultrafilter toremove any remaining bugs or contaminants from the PD dialysate beforeentering the peritoneum of patient 12.

In an embodiment, CFPD system 10 c is primed just as described above inconnection with FIG. 2, wherein arterial line connector 14 a isconnected to venous line connector 16 a, while CFPD connection set 110still resides within its sterile package. Control unit 50 causes PDdialysate to be pumped via blood pump 30 and/or to-dialyzer pump 64until all air is purged from PD patient circuit 90 and pumped to drain.At that point, arterial line connector 14 a and venous line connector 16a are disconnected from each other, CFPD connection set 110 is removedfrom its package, connected to connectors 14 a and 16 a, and purged,e.g., by setting the patient-side tips of lumens at a vertical elevationthat allows gravity to fill and prime CFPD connection set 110. Onceprimed, CFPD connection set 110 is connected to the patient's PDtransfer set, which can include dual indwelling catheters, for example,one that introduces PD solution at a lower end of the patient'speritoneum, and another that removes PD solution from an upper end ofthe patient's peritoneum.

When prime is complete and patient 12 is connected to system 10 c,control unit 50 causes the CFPD circulation illustrated in FIG. 4 totake place. CFPD does not have fills, dwells and drains as with batchPD. Instead, CFPD acts much like hemodialysis, except that blood circuit20 is replaced with PD patient circuit 90. Fresh dialysate pump 64 andspent dialysate pump 96 pump PD dialysate with valves 92 and 94 openthrough the dialysate circuit 70 and dialyzer 40, cleaning the dialysatecirculating through PD patient circuit 90 and pumping used dialysate todrain via drain line 82.

At the same time, control unit 50 causes blood pump 30 to circulate PDdialysate around PD patient circuit 90, into patient 12 via venous line16 and last chance filter 108, across the peritoneum of patient 12, outarterial line 14, and back into blood pump 30. Circulation through dualloops 70 and 90 is continued for a doctor-prescribed amount of time.Online PD dialysate is prepared as needed using purified water from unit60 and concentrate from container 88 as described above. CFPD typicallyrequires a larger amount of PD dialysate than does batch PD.

As with batch PD system 10 b, CFPD system 10 c can be used with baggeddialysate, for example, if it is desired to conserve PD dialysate usage.Here, once PD patient circuit 90 is primed and patient 12 is connectedto the PD patient circuit, control unit 50 instead causes blood pump 30to circulate dialysate around PD patient circuit 90 as before, but nowcauses dialysate circuit valves 92 and 94 to be closed and dialysatecircuit pumps 64 and 96 to remain idle. From time to time, control unit50 can cause dialysate circuit valves 92 and 94 to be opened anddialysate circuit pumps 64 and 96 to be operated to replace a portion ofPD dialysate in circuit 90, which has been running through the patient'speritoneum for some time, with new and fresh dialysate from dialysatecircuit 70. This is more of a convective exchange of used dialysate withfresh dialysate as opposed to the osmotic cleaning performed when bloodpump 30 and dialysate circuit pumps 64 and 96 are operated continuously.

In any case, after CFPD has been performed for the prescribed time oruntil a prescribed PD fluid volume has been consumed, CFPD system isdrained as illustrated in FIG. 5. Here, control unit 50 causes fillvalve 94 to be closed and drain valve 92 to be opened. One or both ofblood pump 30 and spent dialysate pump 96 are operated to pull useddialysate through one or both of arterial line 14 and venous line 16 fora number of strokes prescribed to remove both a fill volume plus anexpected amount of UF from the patient's peritoneum. Control unit 50 canagain count known volume strokes of blood pump 30 and/or spent dialysatepump 96 to arrive at the prescribed removal volume. Also, as discussedabove with FIGS. 1 to 3, if PD treatments are performed back to back,and patient 12 in the second PD treatment arrives at treatment full ofspent PD as is often the case, the second treatment can, after prime andpatient connection have been completed, begin with a drain sequencecontrolled by control unit 50 in the manner just described.

HD and Simplified Batch PD

Referring now to FIGS. 6 and 7, hemodialysis system 10 a of FIG. 1 isused instead in any desired alternating treatment sequence with asimplified batch peritoneal dialysis system 10 d. System 10 d isstructurally similar to that of batch PD system 10 b and CFPD system 10c, so like element numbers, including all structure, function andalternatives discussed above in FIGS. 2 to 5, are repeated and areincluded in FIGS. 6 and 7.

For combination systems 10 a and 10 d, hemodialysis takes place justlike above with FIG. 1. Hemodialysis system 10 a is hot waterdisinfected after treatment, and if a next treatment is scheduled orselected to be a PD treatment, chemical disinfectant from source 86 canbe used to additionally sterilize circuits 70 and 90. Chemicaldisinfectant from source 86 is metered into purified water from unit 60in the same manner described above for FIG. 2.

For batch system 10 d, batch PD connection set 100 of system 10 b isreplaced with a single line connection set 120. Single line connectionset 120 uses a single line and single lumen instead of the “Y” or “T”connector 102, 104, 106 of batch PD connection set 100 or the duallumens of CFPD set 110. Single line connection set 120 is connectedremovably via last chance, single use filter 108 to venous lineconnector 16 a of venous line 16. Filter 108 can again be a finalultrafilter to remove any remaining bugs or contaminants from the PDdialysate before entering the peritoneum of patient 12. Also differentfrom above, a source 122 of premade and sterilized PD dialysate isconnected removably to arterial line connector 14 a of venous line 14.

In an embodiment, simplified batch system 10 d is primed by pumping PDdialysate from source 122 via blood pump 30, through arterial line 14,dialyzer 40, venous line 16, and to an end of single line connection set120. The end of single line connection set 120 (as well as the ends ofsets 100 and 110) can be found either by providing a hydrophobicmembrane at a removable tip of connection set 120 and sensing a pressureincrease at blood pump 30 once the PD dialysate hits the hydrophobictip. Or, the end of the single line connection set 120 (or sets 100 and110) can be set at the same elevation as source 122 (or some otherpressure head source for sets 100 and 110), so that PD dialysate that isgravity fed by opening all valves 32 i, 32 o, 34 i and 34 o of bloodpump 30 comes to rest naturally at the end of single line connection set120.

When prime is complete and patient 12 is connected to system 10 d asillustrated in FIG. 6, control unit 50 causes the batch filling to takeplace via known pump stroke volume blood pump 30. Here, dialysate valves92 and 94 are closed, so that PD dialysate is forced through dialyzer40, through venous line 16, and into the peritoneum of patient 12. Thefill volume is measured by counting and adding the known volume pumpstrokes.

Once the patient's peritoneum is filled to a prescribed fill volume,control unit 50 stops blood pump 30. The PD dialysate is then allowed toreside or dwell within the patient's peritoneum for a prescribed amountof time. Batch system 10 d, like system 10 b, performs multiple fills,dwells and drains. System 10 d, like batch system 10 b, can performtotal drains including expected UF, or perform partial drains and fillsin a tidal peritoneal dialysis modality.

In FIG. 7, control unit 50 causes the batch draining to take place.Here, fresh dialysate fluid valve 94 is closed, while spent dialysatevalve 92 is opened to allow spent dialysate to flow through drain line82 to a house drain or drain container. In one embodiment, from-dialyzerpump 96 is used to pull a prescribed amount of drain fluid, e.g., viacontrol unit 50 counting known volume strokes of pump 96, and push thedrain fluid to drain.

Control unit 50 then repeats the above-described fill, dwell and drainprocess. As before, if patient 12 uses system 10 d to perform peritonealdialysis for multiple treatments in a row, the patient may have a fullperitoneum from the prior PD treatment when first connecting to PDpatient circuit 90. If so, patient 12 can inform control unit 50 ofsame. Or, control unit 50 may already know that patient 12 needs to bedrained and instructs the patient to do so accordingly. In this case,control unit 50 performs an initial drain through primed PD patientcircuit 90 first before performing a first fill. In an alternativeembodiment, patient 12 performs a manual drain and enters the drainweight into control unit 50 before connecting to PD patient circuit 90.

In an alternative draining embodiment, and assuming PD dialysate source122 holds a single fill volume such that the source is emptied in thefill phase of FIG. 6, control unit 50 can instead cause blood pump 30 topump from patient 12 back to source 122. Here, dialysate valves 92 and94 are closed, so that PD dialysate is forced through venous line 16,through dialyzer 40, through arterial line 14, and back into PDdialysate source 122. Dialysate source 122 in this embodiment is sizedto hold an additional amount of UF removed from the patient during thedrain phase.

Pumping Pressures for HD Versus PD

HD typically pumps at higher pressures than does PD. HD blood pumpingpressures can in arterial line 14 before blood pump 30 pump be fromabout −50 mmHg to −300 mmHg. Arterial needle or catheter 14 b restrictsthe inlet to blood pump 30 and creates a slight vacuum. At pressuresbelow −250 mmHg, HD system 10 a may alarm for low blood flow. Thehighest pressure in blood circuit 20 occurs just after blood pump 30.Post blood pump pressure is dependent on blood flow rate, dialyzer 40pressure drop, hematocrit (percentage of red blood cells to whole blood,which determines blood viscosity), needle size for needles 14 b, 16 bsize, and any clotting in venous blood return line 16. Blood pumppressure can be 100 to 200 mmHg higher than the pressure in venous line16, which can for example be 100 to 250 mmHg. The venous pressure willincrease if venous needle 16 b is pushed against the wall of the access.It is contemplated for system 10 a to monitor venous blood pressure from0 to 500 mmHg.

The pressures in the dialysate circuit 70 are dependent on dialyzertype, ultrafiltration rate and the extracorporeal blood pressures.Typical pressure monitoring range is from −500 mmHg to +600 mmHg.Dialysate pressure can be different depending upon whether the pressureis measured at the dialyzer inlet or outlet due to the pressure drop onthe dialysate side of dialyzer 40. The ultrafiltration coefficient ofdialyzer 14 is also variable in the dialysate pressure. Theultrafiltration coefficient is the number of milliliters of fluidremoved per hour per mmHg. It is contemplated that dialysate remainpositive as much as possible to prevent the pulling of air from thedialysate solution.

PD dialysate pumping pressures are less and can be, for example, up tothree psig positive pumping pressure and as low as −1.5 psig negativepumping pressure. Or, PD dialysate pumping pressures can be about 78mmHG for filling and draining. Pumping to and from the patient'speritoneum must be done at lower pressures to prevent patient discomfortand potential patient harm. HD pressures are higher due to the flowratesinvolved and having to push and pull blood through one or more needle.It is therefore necessary that each combination of systems 10 a/10 b, 10a/10 c and 10 a/10 d be able to provide the desired operating pressuresfor both HD and PD. FIGS. 8 to 10 provide different alternatives forachieving different pump pressures for the different treatments. Thealternatives for FIGS. 8 to 10 apply to each combination of systems 10a/10 b, 10 a/10 c and 10 a/10 d.

Referring now to FIG. 8, system combinations 10 a/10 b, 10 a/10 c and 10a/10 d can each employ a pneumatic pressurization system 150.Pressurization system 150 supplies the positive and negative airpressure to each of the pumps and possibly to each of the valves ofsystem combinations 10 a/10 b, 10 a/10 c and 10 a/10 d. Pressurizationsystem 150 is under control of control unit 50 of each of systemcombinations 10 a/10 b, 10 a/10 c and 10 a/10 d, and each dashed line inFIG. 8 corresponds to a data or electrical connection with control unit50.

Pressurization system 150 includes a positive air compressor 152 and anegative air compressor 154. Positive air compressor 152 is in pneumaticcommunication via pneumatic line 156 with a HiPos air supply tank 160and a LoPos air supply tank 162. Negative air compressor 154 is inpneumatic communication via pneumatic line 158 with a HiNeg air supplytank 164 and a LoNeg air supply tank 166. Positive air compressor 152pressurizes HiPos air supply tank 160 to the highest positive pressureneeded for HD dialysate and blood pumping. Positive air compressor 152pressurizes LoPos air supply tank 162 to the highest positive pressureneeded for PD dialysate pumping. Negative air compressor 154 evacuatesHiNeg air supply tank 164 to the highest negative pressure needed for HDdialysate and blood pumping. Negative air compressor 154 evacuates LoNegair supply tank 166 to the highest negative pressure needed for PDdialysate pumping. Each of the four pressures is achieved in therespective tanks through feedback to control unit 50 via an electronicpressure gauge 168, wherein compressors 152 and 154 are operated untilthe corresponding pressure gauge 168 indicates that the desired positiveor negative pressure resides in the respective tank.

Pressurization system 150 includes electrically controlled solenoidvalves 170, 172, 174 and 176 that control unit 50 opens and closes toallow HD pressure (HiPos, HiNeg) or PD pressure (LoPos, LoNeg) to beused as needed. If valve 170 is opened, HiPos air is communicated viaoutlet line 180 with each of a plurality of pneumatic pump controlvalves, which are in turn controlled via control unit 50 to selectivelyclose the pump membranes of pumps 30, 64 and 96 for HD. If valve 172 isopened, LoPos air is communicated instead via outlet line 180 with eachof the pneumatic pump control valves, which are in turn controlled viacontrol unit 50 to selectively close the pump membranes of pumps 30, 64and 96 for PD. If valve 174 is opened, HiNeg air is communicated viaoutlet line 182 with each of the pneumatic pump control valves, whichare in turn controlled via control unit 50 to selectively open the pumpmembranes of pumps 30, 64 and 96 for HD. If valve 176 is opened, LoPosair is communicated instead via outlet line 182 with each of thepneumatic pump control valves, which are in turn controlled via controlunit 50 to selectively open the pump membranes of pumps 30, 64 and 96for PD.

In an alternative version of FIG. 8, for example if the HD and PDtherapies each require different positive and negative pressures fordifferent purposes, e.g., pump membrane versus valve membrane ordialysate pumping versus blood pumping, each of tanks 160, 162, 164 and166 can be set on a given day for an HD treatment or a PD treatment.Thus both HiPos and LoPos tanks 160 and 162 could be set on a given dayfor HD or PD, while both HiNeg and LoNeg tanks 164 and 166 arecorrespondingly set on the given day for HD or PD. In this alternativeversion, separate outlet lines 180 are provided for each of HiPos andLoPos tanks 160 and 162, while separate outlet lines 182 are providedfor each of HiNeg and LoNeg tanks 164 and 166. Separate outlet linesallow for simultaneous use of different positive and negative pressures.

Referring now to FIG. 9, system combinations 10 a/10 b, 10 a/10 c and 10a/10 d can each alternatively employ a pneumatic pressurization system190. Pressurization system 190 supplies the positive or negative airpressure to each of the pumps and possibly to each of the valves ofsystem combinations 10 a/10 b, 10 a/10 c and 10 a/10 d. Pressurizationsystem 190 is likewise under control of control unit 50 of each ofsystem combinations 10 a/10 b, 10 a/10 c and 10 a/10 d, and each dashedline in FIG. 9 corresponds to a data or electrical connection withcontrol unit 50.

Pressurization system 190 likewise includes a positive air compressor152 and a negative air compressor 154. Positive air compressor 152 is inpneumatic communication with a Pos air supply tank 192. Negative aircompressor 154 is in pneumatic communication with a Neg air supply tank194. Positive air compressor 152 pressurizes Pos air supply tank 192 tothe highest positive pressure needed that day for either for HD bloodpumping, HD dialysate pumping or PD dialysate pumping. Negative aircompressor 194 evacuates Neg air supply tank 194 to the highest negativepressure needed that day for HD dialysate or blood pumping or PDdialysate pumping. Each of tank pressure is again achieved throughfeedback to control unit 50 via an electronic pressure gauge 168,wherein compressors 152 and 154 are operated until the correspondingpressure gauge 168 indicates that the desired positive or negativepressure resides in the respective tank 192 or 194.

An electrically controlled positive pressure air regulator 196 isprovided to regulate down the pressure of the air received from positivetank 192 if needed. Thus if tank 192 is pressurized to the positivepressure needed for HD pumping, control unit 50 could electricallycontrol positive pressure air regulator 196 to limit the pressure to thelevel needed for PD dialysate pumping. Or, control unit 50 couldelectrically control positive pressure air regulator 196 to limit thepressure to the level needed for an HD pump or valve purpose needingless positive pressure than which resides in tank 192. Likewise, if Negair tank 194 is pressurized to the negative pressure needed for HDpumping, control unit 50 could electrically control negative airregulator 198 to limit the negative pressure to the level needed for PDdialysate pumping. Or, control unit 50 could electrically controlnegative air regulator 198 to limit the pressure to the level needed foran HD pump or valve purpose needing less positive pressure than whichresides in tank 194.

Downstream pressure gauges 168 are used to provide feedback to controlunit 50, so that control unit 50 can servo air regulators 196 and 198 toachieve the desired pump or valve positive or negative operatingpressure. While a single positive pressure air regulator 196 isillustrated operating with positive tank 192, multiple positive pressureair regulators 196 can be provided alternatively for different,simultaneous positive air pressure pumping or valve actuation. Likewise,while a single negative pressure air regulator 198 is illustratedoperating with negative tank 194, multiple negative pressure airregulators 198 can be provided alternatively for different, simultaneousnegative air pressure pumping or valve actuation.

Up until now, the focus of this application has been on the use ofpneumatic pumps and valves. In an alternative embodiment illustrated inconnection with FIG. 10, any or more or all of pumps 30, 64 and 96 ofsystem combinations 10 a/10 b, 10 a/10 c and 10 a/10 d can alternativelybe an electrically driven pump, such as a peristaltic tubing pump 212.Control unit 50 causes a roller of peristaltic tubing pump 212 to rotateclockwise in FIG. 10 to push fluid (blood or dialysate) under positiveto a destination, such as patient 12 or dialyzer 40. Control unit 50causes the roller of peristaltic tubing pump 212 to rotatecounterclockwise in FIG. 10 to pull fluid (blood or dialysate) undernegative pressure through line 214 from a source, such as patient 12 ordialyzer 40.

Control unit 50 sets the positive and negative pumping pressures bychanging the speed of the rotation of the roller of pump 212. Downstreamelectronic pressure gauges 214 and 216 provide positive and negativepressure feedback, respectively, to control unit 50. Control unit 50uses the pressure signal feedback to set the speed of roller pump 212 toachieve a desired positive or negative pressure at pressure gauges 214and 216.

Also until now, volumetric control of the blood and dialysate pumps hasbeen performed by counting and adding known volume pump strokes. It iscontemplated to use other forms of volumetric control. First, any ofsystem combinations 10 a/10 b, 10 a/10 c and 10 a/10 d can relyalternatively on the use of balance chambers to control dialysate orblood flow volume. Balance chambers are disclosed in the referencedpublications. FIG. 10 illustrates is similar type of metering system 220used with peristaltic pump 212. Metering system 220 includes two inletvalves 222 and 224 under control of control unit 50, two outlet valves226 and 228 under control of control unit 50, and a central known volumepod 230 having a diaphragm 232 that flaps back and forth within pod 230,similar to the diaphragms or membranes located within pumps 30, 64 and96.

Control unit 50 opens and closes valves 222 and 228 at the same time,and opens and closes valves 224 and 226 at the same time. Opening valve222 allows fluid pressure to cause diaphragm 232 to move and expel aknown volume of fluid through valve 228 to outlet line 234. Openingvalve 224 allows fluid pressure to cause diaphragm 232 to move and expela known volume of fluid through valve 226 to outlet line 234. Fluid flowcan take place alternatively under negative pressure from line 234,through metering system 220, to pump 212. By metering flow in such away, control unit 50 knows how much fluid that roller pump 212 ispumping by counting how many times valves 222 to 228 are sequenced.Thus, peristaltic pump 212 is not relied upon for pumping accuracy, butis, as discussed above controlled to achieve a desired positive ornegative pressure at line 234.

While pneumatic valves could be used with electrically controlledperistaltic pump 212, it is also contemplated to eliminate thepneumatics altogether from any of the system combinations above. Hereinstead, electrically activated pinch or solenoid clamps or valves underthe control of control unit 50, such as for valves 222, 224, 226 and228, can be used.

Other forms of blood and dialysate flow volume control may be usedalternatively or in addition to one or more of the above-describedvolume control methods. For example, one or more weigh scale incommunication with control unit 50 may be used. In another example, avolume calculation using the ideal gas equation may be used. One suchsystem and method is described in U.S. Pat. No. 8,197,439, entitled,“Fluid Volume Determination For Medical Treatment System”, the entirecontents of which are incorporated herein by reference and relied upon.

Additional Aspects of the Present Disclosure

Aspects of the subject matter described herein may be useful alone or incombination with any one or more of the other aspect described herein.Without limiting the foregoing description, in a first aspect of thepresent disclosure a dialysis system includes: a dialysis fluid pumpreceptacle actuated by a dialysis fluid pump actuator; a dialysis fluidline; a blood filter in fluid communication with the dialysis fluid pumpreceptacle via the dialysis fluid line; an extracorporeal circuitconnectable to a patient; a blood pump receptacle actuated by a bloodpump actuator, the blood pump receptacle in fluid communication with theblood filter via the extracorporeal circuit; and a control unitprogrammed to (i) in a first treatment pump peritoneal dialysis fluidthrough the dialysis fluid pump receptacle, the dialysis fluid line, theblood filter, the extracorporeal circuit and the blood pump receptacleto the patient's peritoneum by operating at least one of the dialysisfluid pump actuator and the blood pump actuator at a first pressure, and(ii) in a second treatment pump blood through the extracorporealcircuit, the blood pump receptacle and the blood filter to the patientby operating the blood pump actuator at a second, different pressure.

In accordance with a second aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, the second pressure is greater than the first pressure.

In accordance with a third aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, at least one of the dialysis fluid pump receptacle andthe blood pump receptacle includes a chamber housing a moveablediaphragm.

In accordance with a fourth aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, at least one of the dialysis fluid pump receptacle andthe blood pump receptacle includes a tube section.

In accordance with a fifth aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, the control unit in the second treatment is furtherprogrammed to pump hemodialysis fluid through the dialysis fluid pumpreceptacle, the dialysis fluid line and the blood filter by operatingthe dialysis fluid pump actuator at a pressure different than the firstpressure.

In accordance with a sixth aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, the control unit in the first treatment operates thedialysis fluid pump actuator and the blood pump actuator at the samefirst pressure.

In accordance with a seventh aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, the dialysis fluid pump receptacle is a first dialysisfluid pump receptacle, the dialysis fluid pump actuator is a firstdialysis fluid pump actuator, and the dialysis fluid line is a firstdialysis fluid line, and which includes a second dialysis fluid pumpreceptacle, a second dialysis fluid pump actuator, and a second dialysisfluid line, the blood filter in fluid communication with the seconddialysis fluid pump receptacle via the second dialysis fluid line; andwherein the control unit is configured to cause the second dialysisfluid pump actuator to pump used peritoneal dialysis fluid or usedhemodialysis fluid from the filter and through the second dialysis fluidline.

In accordance with an eighth aspect of the present disclosure, which maybe used in combination with the seventh aspect and any other aspect orcombination of aspects listed herein, in the first treatment, the seconddialysis fluid pump actuator pumps used peritoneal dialysis fluid in twodirections through the through the extracorporeal circuit to the bloodfilter.

In accordance with a ninth aspect of the present disclosure, which maybe used in combination with the eighth aspect and any other aspect orcombination of aspects listed herein, one of the directions through theextracorporeal includes the blood pump receptacle, and wherein usedperitoneal dialysis fluid flow in that direction is aided by the bloodpump actuator.

In accordance with a tenth aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, in the first treatment, the first dialysis fluid pumpactuator pumps fresh peritoneal dialysis fluid through the blood filterand in two directions through the extracorporeal circuit to thepatient's peritoneum.

In accordance with an eleventh aspect of the present disclosure, whichmay be used in combination with the tenth aspect and any other aspect orcombination of aspects listed herein, one of the directions through theextracorporeal includes the blood pump receptacle, and wherein freshperitoneal dialysis fluid flow in that direction is aided by the bloodpump actuator.

In accordance with a twelfth aspect of the present disclosure, which maybe used in combination with any other aspect or combination of aspectslisted herein, a dialysis system includes: a dialysis fluid pumpreceptacle actuated by a dialysis fluid pump actuator; a dialysis fluidline; a blood filter in fluid communication with the dialysis fluid pumpreceptacle via the dialysis fluid line; an extracorporeal circuitconnectable to a patient; a blood pump receptacle actuated by a bloodpump actuator, the blood pump receptacle in fluid communication with theblood filter via the extracorporeal circuit; and a control unitprogrammed to (i) in a first treatment create peritoneal dialysis fluidby combining purified water with a peritoneal dialysis concentrate, and(ii) in a second treatment create hemodialysis fluid by combiningpurified water with a hemodialysis concentrate.

In accordance with a thirteenth aspect of the present disclosure, whichmay be used in combination with the twelfth aspect and any other aspector combination of aspects listed herein, the dialysis system includes aplurality of conductivity sensors in operable communication with thecontrol unit and the hemodialysis fluid as the fluid is combined forcontrolling the combining purified water with the hemodialysisconcentrate.

In accordance with a fourteenth aspect of the present disclosure, whichmay be used in combination with the twelfth aspect and any other aspector combination of aspects listed herein, the dialysis system includes atleast one proportioning pump for pumping the purified water and theperitoneal dialysis concentrate, the at least one proportioning pump inoperable communication with the control unit for controlling thecombining of the peritoneal dialysis fluid.

In accordance with a fifteenth aspect of the present disclosure, whichmay be used in combination with any other aspect or combination ofaspects listed herein, a dialysis system includes: a first dialysisfluid pump receptacle actuated by a first dialysis fluid pump actuator;a first dialysis fluid line; a second dialysis fluid pump receptacleactuated by a second dialysis fluid pump actuator; a second dialysisfluid line; a blood filter in fluid communication with the firstdialysis fluid pump receptacle via the first dialysis fluid line and thesecond dialysis fluid pump receptacle via the second dialysis fluidline; an extracorporeal circuit connectable to a patient; a blood pumpreceptacle actuated by a blood pump actuator, the blood pump receptaclein fluid communication with the blood filter via the extracorporealcircuit; and a control unit programmed to (i) in a first treatment pumpperitoneal dialysis fluid in a continuous flow manner through the firstdialysis fluid pump receptacle, the first dialysis fluid line, the bloodfilter, the extracorporeal circuit, the blood pump receptacle, thepatient's peritoneum, back through the blood filter, the second dialysisfluid line, and the second dialysis fluid pump receptacle by operatingat least two of the first dialysis fluid pump actuator, the seconddialysis fluid pump actuator and the blood pump actuator, and (ii) in asecond treatment pump blood through the extracorporeal circuit, theblood pump receptacle and the blood filter to the patient by operatingthe blood pump.

In accordance with a sixteenth aspect of the present disclosure, whichmay be used in combination with the fifteenth aspect and any otheraspect or combination of aspects listed herein, the control unit in thesecond blood treatment is programmed to cause (i) the first dialysisfluid pump actuator to pump fresh hemodialysis fluid through the firstdialysis fluid pump receptacle, the first dialysis fluid line and theblood filter and (ii) the second dialysis fluid pump actuator to pumpused hemodialysis from the blood filter through the second dialysisfluid pump receptacle and the second dialysis fluid line.

In accordance with a seventeenth aspect of the present disclosure, whichmay be used in combination with the fifteenth aspect and any otheraspect or combination of aspects listed herein, in the first treatment,the blood pump actuator pumps used peritoneal dialysis fluid through theblood pump receptacle back to the blood filter.

In accordance with an eighteenth aspect of the present disclosure, whichmay be used in combination with the fifteenth aspect and any otheraspect or combination of aspects listed herein, in the first treatment,the first dialysis fluid pump actuator pumps fresh peritoneal dialysisfluid through the blood filter, through a portion of the extracorporealcircuit, to the patient's peritoneum.

In accordance with a nineteenth aspect of the present disclosure, whichmay be used in combination with any other aspect or combination ofaspects listed herein, a dialysis system includes: a dialysis fluid pumpreceptacle actuated by a dialysis fluid pump actuator; a dialysis fluidline; a blood filter in fluid communication with the dialysis fluid pumpreceptacle via the dialysis fluid line; an extracorporeal circuitconnectable to a patient; a blood pump receptacle actuated by a bloodpump actuator, the blood pump receptacle in fluid communication with theblood filter via the extracorporeal circuit; and a control unitprogrammed to (i) in a first treatment pump peritoneal dialysis fluidfrom a source, through the extracorporeal circuit, the blood pumpreceptacle and the blood filter to the patient by operating the bloodpump actuator, and (ii) in a second treatment pump blood through theextracorporeal circuit, the blood pump receptacle and the blood filterto the patient by operating the blood pump actuator.

In accordance with a twentieth aspect of the present disclosure, whichmay be used in combination with the nineteenth aspect and any otheraspect or combination of aspects listed herein, in the first treatmentthe dialysis fluid line is occluded and in the second treatment thedialysis fluid line is open for at least part of the treatment.

In accordance with a twenty-first aspect of the present disclosure, anyof the structure and functionality illustrated and described inconnection with FIGS. 1 to 10 may be used in combination with any otheraspect or combination of aspects listed herein.

It should be understood that various changes and modifications to thepresently preferred embodiments described herein will be apparent tothose skilled in the art. Such changes and modifications can be madewithout departing from the spirit and scope of the present subjectmatter and without diminishing its intended advantages. It is thereforeintended that such changes and modifications be covered by the appendedclaims.

The invention is claimed as follows:
 1. A dialysis system comprising: atleast one source of fluid for dialysis; a fluid line in fluidcommunication with the at least one source of fluid; at least one pumppositioned and arranged to pump fluid from the at least one source offluid through the fluid line; a first patient connector configured to beremovably placed in fluid communication with the fluid line to allow ablood treatment to be performed using the at least one source of fluid;and a second patient connector configured to be removably placed influid communication with the fluid line to allow a peritoneal dialysistreatment to be performed using the at least one source of fluid.
 2. Thedialysis fluid system of claim 1, wherein the first patient connectorincludes hemodialysis needles.
 3. The dialysis fluid system of claim 1,wherein the second patient connector includes a peritoneal dialysisconnection set.
 4. The dialysis fluid system of claim 1, wherein thefirst patient connector and the second patient connecter are configuredto be attached interchangeably at a same location of the dialysissystem.
 5. The dialysis fluid system of claim 4, wherein the fluid lineis a dialysis fluid line, and which further includes a blood filter influid communication with the dialysis fluid line and an extracorporealcircuit in fluid communication with the blood filter, and wherein thefirst patient connector and the second patient connector are configuredto be attached interchangeably to the extracorporeal circuit.
 6. Thedialysis fluid system of claim 5, wherein the extracorporeal circuitincludes an arterial line connector and a venous line connector, andwherein the first patient connector and the second patient connector areconfigured to be attached interchangeably to at least one of thearterial and venous line connectors.
 7. The dialysis fluid system ofclaim 6, wherein the first patient connector includes a venous lumenconfigured to be removably attached to the venous line connector and anarterial lumen configured to be removably attached to the arterial lineconnector.
 8. The dialysis fluid system of claim 6, wherein the secondpatient connector includes a peritoneal dialysis connection setconfigured to be removably attached to at least one of the venous lineconnector and the arterial line connector.
 9. The dialysis fluid systemof claim 1, wherein the at least one source of fluid includes a waterpurification machine and at least one source of concentrate.
 10. Thedialysis fluid system of claim 9, wherein the at least one source ofconcentrate includes at least one of: (i) an acid container; (ii) abicarbonate cartridge; or (iii) at least one peritoneal dialysisconcentrate source.
 11. The dialysis fluid system of claim 1, whichincludes a control unit programmed to pump dialysis fluid from the atleast one source of fluid through a blood filter to perform theperitoneal dialysis treatment with the second patient connector.
 12. Thedialysis fluid system of claim 1, which includes a control unitprogrammed to drain a patient using the second connector when aperitoneal dialysis treatment is to be performed.
 13. A dialysis systemcomprising: a water purification unit; at least one pump in fluidcommunication with the water purification unit; a first at least onesource of concentrate that creates peritoneal dialysis fluid when mixedwith water from the water purification unit; a second at least onesource of concentrate that creates dialysis fluid for blood treatmentwhen mixed with water from the water purification unit; a peritonealdialysis connection set; a blood filter; and a control unit programmedto: (i) control the at least one pump to perform a peritoneal dialysistreatment by (a) mixing water from the water purification unit withconcentrate from the first at least one source of concentrate to createthe peritoneal dialysis fluid, and (b) delivering the peritonealdialysis fluid to a patient via the peritoneal dialysis connection set;and (ii) control the at least one pump to perform a hemodialysistreatment by (a) mixing water from the water purification unit withconcentrate from the second at least one source of concentrate to createthe dialysis fluid for blood treatment, and (b) delivering the dialysisfluid for blood treatment to the blood filter to filter the patient'sblood.
 14. The dialysis fluid system of claim 13, wherein the first atleast one source of concentrate and the second at least one source ofconcentrate are interchangeably fluidly communicated with the at leastone pump.
 15. The dialysis fluid system of claim 13, wherein theperitoneal dialysis connection set is removably fluidly communicatedwith the at least one pump.
 16. The dialysis fluid system of claim 13,which includes at least one conductivity sensor, the control unitprogrammed to use output data from the at least one conductivity sensorto mix the water with concentrate.
 17. The dialysis fluid system ofclaim 13, wherein the control unit is programmed to control the at leastone pump to pump the peritoneal dialysis fluid through the blood filterduring the peritoneal dialysis treatment.
 18. A dialysis systemcomprising: a dialysis fluid pump; a dialysis fluid line; a blood filterin fluid communication with the dialysis fluid pump via the dialysisfluid line; an extracorporeal circuit connectable to a patient; a bloodpump in fluid communication with the blood filter via the extracorporealcircuit; at least one peritoneal dialysis concentrate; at least oneblood treatment concentrate; and a control unit programmed to: (i) in afirst treatment create peritoneal dialysis fluid by combining purifiedwater with the at least one peritoneal dialysis concentrate; and (ii) ina second treatment create dialysis fluid for blood treatment bycombining purified water with the at least one blood treatmentconcentrate.
 19. The dialysis system of claim 18, which includes atleast one conductivity sensor, the control unit programmed to use outputdata from the at least one conductivity sensor to combine the purifiedwater with the at least one blood treatment concentrate.
 20. Thedialysis system of claim 18, which includes at least one proportioningpump under control of the control unit for pumping the purified waterand the at least one peritoneal dialysis concentrate.